Antenatal Dexamethasone and Decreased Birth Weight

@article{Bloom2001AntenatalDA,
  title={Antenatal Dexamethasone and Decreased Birth Weight},
  author={S. Bloom and J. Sheffield and D. Mcintire and K. Leveno},
  journal={Obstetrics \& Gynecology},
  year={2001},
  volume={97},
  pages={485–490}
}
Objective To test the hypothesis that antenatal dexamethasone treatment to promote fetal lung maturation results in decreased birth weight corrected for gestational age. Methods The birth weights of all dexamethasone-treated, singleton, live-born infants delivered at our hospital were compared with our overall obstetric population; a group of untreated infants frequency matched approximately 3:1 according to maternal race, infant sex, and gestational age at delivery; and an historical cohort of… Expand
Effect of prenatal glucocorticoid treatment on size at birth among infants born at term gestation
TLDR
Prenatal treatment with a single course of GCs was associated with a reduction in size at birth among infants born at term gestation, and this effect cannot be explained by differences in fetal size before treatment or exposure to preterm labor. Expand
Does Antenatal Corticosteroid Therapy Affect Birth Weight and Head Circumference?
TLDR
A retrospective analysis of non‐anomalous newborns admitted to 100 neonatal intensive care units using multivariable analysis of variance suggested that antenatal corticosteroids were associated with a greater reduction in brain growth than somatic growth. Expand
Effect of Antenatal Corticosteroid Treatment on Lung Function in Full-Term Newborn Infants
TLDR
The testing of the hypothesis that changes within lung acini, induced by maternal corticosteroid treatment, persist during lung development contributes to an emerging body of evidence that antenatal treatment with Corticosteroids does not permanently affect lung structure or function. Expand
Corticosteroid Use in Special Circumstances: Preterm Ruptured Membranes, Hypertension, Fetal Growth Restriction, Multiple Fetuses
TLDR
This study found that infants born before 34 weeks’ gestation had a significantly lower incidence of respiratory distress and neonatal mortality from hyaline membrane disease if birth was delayed for at least 24 hours after completion of 24 hours of betamethasone given to the mother. Expand
Association between birth weight in preterm neonates and the BclI polymorphism of the glucocorticoid receptor gene
TLDR
The results suggest that the BclI polymorphism of the glucocorticoid receptor gene may have an impact on gestational age-adjusted birth weight, but it does not influence perinatal morbidities of preterm neonates. Expand
Committee Opinion No.677: Antenatal Corticosteroid Therapy for Fetal Maturation.
  • Medicine
  • Obstetrics and gynecology
  • 2016
TLDR
A single repeat course of antenatal corticosteroids should be considered in women who are less than 34 0/7 weeks of gestation who have an imminent risk of preterm delivery within the next 7 days, and whose prior course was administered more than 14 days previously. Expand
Impact of antenatal corticosteroids on head circumference of full-term newborns: a French multicentre cohort study.
TLDR
It is found that children exposed to antenatal corticosteroids had a higher risk of a birth length below the fifth percentile when compared to those with neither exposure to threatened preterm labour nor cortic Fosteroids. Expand
Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation.
  • Medicine
  • Obstetrics and gynecology
  • 2017
TLDR
A single repeat course of corticosteroids should be considered in women who are less than 34 0/7 weeks of gestation who are at risk of preterm delivery within 7 days, and whose prior course of antenatal cortiosteroids was administered more than 14 days previously. Expand
Single Versus Repeat Courses of Antenatal Steroids to Improve Neonatal Outcomes: Risks and Benefits
TLDR
Although there is evidence demonstrating the safety of a single repeat, or “rescue”, dose of antenatal corticosteroids, this must be tempered against the adverse effects seen after multiple courses of weekly repeat steroids. Expand
Antenatal corticosteroid treatment: factors other than lung maturation
  • K. Haram, J. Mortensen, E. Magann, J. Morrison
  • Medicine
  • The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
  • 2017
TLDR
Antenatal corticosteroid therapy improves both fetal lung mechanism and gas exchange due to accelerated morphologic development of type one and two pneumocytes and enhances the production of surfactant binding proteins and fetal lung antioxidant enzymes. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 19 REFERENCES
Repeated antenatal corticosteroids: size at birth and subsequent development.
TLDR
In this cohort study repeated corticosteroid courses were associated with adverse effects on size at birth without apparent benefits, which have the potential to affect later development. Expand
Birth weight in relation to morbidity and mortality among newborn infants.
TLDR
Mortality and morbidity are increased among infants born at term whose birth weights are at or below the 3rd percentile for their gestational age, and these differences persisted after adjustment for the mother's race and parity and the infant's sex. Expand
Randomized study of the effect of antenatal dexamethasone on growth and development of premature children at the corrected age of 2 years
TLDR
The follow‐up results indicate that the beneficial effect of prenatal glucocorticoid treatment on cerebral complications I intraventricular haemorrhage or periventricular leucomalacia demonstrated during the neonatal period may be followed by a lower incidence of cerebral palsy in surviving premature children. Expand
Maternal, but not fetal, administration of corticosteroids restricts fetal growth.
TLDR
Administration of repeated doses of betamethasone directly to the sheep fetus does not produce the growth-restricting effects induced by maternal administration and does not affect the placental/birthweight ratio. Expand
Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs.
TLDR
Repetitive 7-d interval exposures of fetal lambs to glucocorticoids progressively enhanced postnatal lung function and resulted in growth and endocrine abnormalities. Expand
Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group.
TLDR
In this retrospective analysis multiple courses of antenatal corticosteroids did not improve outcome and were associated with increased mortality, decreased fetal growth, and prolonged adrenal suppression. Expand
Dose effects of antenatal corticosteroids for induction of lung maturation in preterm rabbits.
TLDR
The induction of lung maturation by corticosteroids has multiple targets in the developing lung and does not exhibit a linear dose response, without increasing surfactant pool size. Expand
Effects of antenatal dexamethasone administration in the infant: long-term follow-up.
  • Medicine
  • The Journal of pediatrics
  • 1984
TLDR
It is concluded that no detectable growth, physical, motor, or developmental deficiencies within the first 3 years of life can be attributed to antenatal dexamethasone therapy in the mothers just prior to delivery. Expand
First-trimester growth and the risk of low birth weight.
TLDR
Suboptimal first-trimester growth may be associated with low birth weight, low birth-weight percentile, and premature delivery. Expand
Effect of corticosteroids for fetal maturation on perinatal outcomes.
TLDR
The consensus panel concluded that antenatal corticosteroid therapy for fetal maturation reduces mortality, respiratory distress syndrome, and intraventricular hemorrhage in preterm infants and will result in a substantial decrease in neonatal morbidity and mortality, as well as substantial savings in health care costs. Expand
...
1
2
...